ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 78 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 13.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $363,000 | -43.2% | 82,589 | -6.2% | 0.00% | – |
| Q1 2021 | $639,000 | -69.9% | 88,078 | -82.1% | 0.00% | – |
| Q4 2020 | $2,121,000 | -68.7% | 490,962 | -70.3% | 0.00% | -100.0% |
| Q3 2020 | $6,785,000 | -47.7% | 1,650,855 | -23.6% | 0.00% | -66.7% |
| Q2 2020 | $12,961,000 | -27.3% | 2,160,253 | -8.8% | 0.00% | -40.0% |
| Q1 2020 | $17,836,000 | -59.7% | 2,368,770 | -26.4% | 0.01% | -44.4% |
| Q4 2019 | $44,262,000 | +296.4% | 3,219,055 | +242.5% | 0.01% | +200.0% |
| Q3 2019 | $11,167,000 | -7.5% | 939,958 | +8.9% | 0.00% | 0.0% |
| Q2 2019 | $12,074,000 | – | 863,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,931,185 | $12,047,000 | 4.29% |
| RA Capital Management | 12,315,213 | $50,616,000 | 0.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $28,562,000 | 0.70% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 620,233 | $2,549,000 | 0.35% |
| Casdin Capital, LLC | 1,870,000 | $7,686,000 | 0.34% |
| Vivo Capital, LLC | 1,325,736 | $5,449,000 | 0.32% |
| Bleichroeder LP | 250,000 | $1,028,000 | 0.18% |
| Virtus ETF Advisers LLC | 40,292 | $166,000 | 0.09% |
| Forefront Analytics, LLC | 30,369 | $123,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 411,977 | $1,693,000 | 0.04% |